Table 4.
Groups | Animal number |
Days after dosing | |||
0 d | 7 d | 14 d | 28 d | ||
NC | 10 | 5.92±1.79 | 6.23±1.75* | 5.91±1.57* | 6.43±1.72* |
DC | 10 | 22.19±3.45* | 22.51±2.11* | 22.60±3.39* | 22.41±2.71* |
DHF | 10 | 22.15±3.45* | 19.27±2.22*# | 16.75±1.95*# | 14.56±2.37*# |
DMF | 10 | 22.70±3.40* | 17.20±2.34*# | 13.83±2.78*# | 9.72±2.22*# |
DLF | 10 | 22.29±3.37* | 19.34±2.66*# | 16.99±2.45*# | 14.34±2.53*# |
DG | 10 | 22.72±3.70* | 11.52±1.71*# | 9.91±2.15*# | 7.08±1.08* |
n=10; (mean±S.D., g);
P < 0.05 as compared with normal control group.;
P < 0.05 as compared with diabetic control Group